SIMILAR PATTERNS OF AMINO ACIDS FOR 4WA5_A_ZMRA501
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ms8 | TRANS-SIALIDASE (Trypanosomacruzi) |
PF13385(Laminin_G_3)PF13859(BNR_3) | 6 | ARG A 35ASP A 59GLU A 230ARG A 245ARG A 314TYR A 342 | DAN A 700 (-3.0A)DAN A 700 (-2.7A)DAN A 700 (-3.3A)DAN A 700 (-2.8A)DAN A 700 (-3.0A)DAN A 700 (-3.5A) | 0.99A | 4wa5A-1ms8A:8.1 | 4wa5A-1ms8A:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mz5 | SIALIDASE (Trypanosomarangeli) |
PF13385(Laminin_G_3)PF13859(BNR_3) | 6 | ARG A 36ASP A 60GLU A 231ARG A 246ARG A 315TYR A 343 | None | 0.83A | 4wa5A-1mz5A:11.6 | 4wa5A-1mz5A:20.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | ARG N 118ASP N 151GLU N 227ALA N 246GLU N 276GLU N 277ARG N 292ASN N 294ARG N 371 | None | 0.93A | 4wa5A-1nmbN:61.3 | 4wa5A-1nmbN:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG N 118GLU N 119GLU N 227ALA N 246GLU N 276GLU N 277ARG N 292ASN N 294ARG N 371TYR N 406 | None | 0.70A | 4wa5A-1nmbN:61.3 | 4wa5A-1nmbN:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU N 227ALA N 246ARG N 292ASN N 294TYR N 406 | None | 1.20A | 4wa5A-1nmbN:61.3 | 4wa5A-1nmbN:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v0z | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 124GLU A 125ASP A 157GLU A 234ALA A 253GLU A 283GLU A 284ARG A 299ASN A 301ARG A 378TYR A 412 | None | 0.55A | 4wa5A-1v0zA:62.9 | 4wa5A-1v0zA:48.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 10 | ARG A 116GLU A 117ASP A 149GLU A 226ALA A 245GLU A 276ARG A 292ASN A 294ARG A 374TYR A 409 | IBA A 1 (-3.3A)IBA A 1 (-3.9A)IBA A 1 (-3.6A)IBA A 1 (-3.9A)IBA A 1 ( 3.9A)IBA A 1 (-3.9A)IBA A 1 (-3.5A)IBA A 1 ( 3.9A)IBA A 1 (-3.2A)None | 0.67A | 4wa5A-1vcjA:52.5 | 4wa5A-1vcjA:35.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 5 | ARG A 116GLU A 117GLU A 275ARG A 374TYR A 409 | IBA A 1 (-3.3A)IBA A 1 (-3.9A)IBA A 1 (-4.1A)IBA A 1 (-3.2A)None | 1.17A | 4wa5A-1vcjA:52.5 | 4wa5A-1vcjA:35.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 5 | GLU A 226ALA A 245ARG A 292ASN A 294TYR A 409 | IBA A 1 (-3.9A)IBA A 1 ( 3.9A)IBA A 1 (-3.5A)IBA A 1 ( 3.9A)None | 1.13A | 4wa5A-1vcjA:52.5 | 4wa5A-1vcjA:35.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w8o | BACTERIAL SIALIDASE (Micromonosporaviridifaciens) |
PF00754(F5_F8_type_C)PF10633(NPCBM_assoc)PF13088(BNR_2) | 5 | ARG A 68GLU A 260ARG A 276ARG A 342TYR A 370 | CIT A1649 ( 2.6A)GOL A1651 (-3.6A)CIT A1649 ( 2.7A)CIT A1649 ( 2.9A)CIT A1649 (-4.5A) | 0.40A | 4wa5A-1w8oA:22.6 | 4wa5A-1w8oA:21.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.19A | 4wa5A-1xogA:62.3 | 4wa5A-1xogA:44.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 119GLU A 120ASP A 152GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)ABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.59A | 4wa5A-1xogA:62.3 | 4wa5A-1xogA:44.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.41A | 4wa5A-1xogA:62.3 | 4wa5A-1xogA:44.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | GLU A 120GLU A 229ALA A 248GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.69A | 4wa5A-1xogA:62.3 | 4wa5A-1xogA:44.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) |
PF13088(BNR_2) | 6 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.68A | 4wa5A-2bf6A:10.2 | 4wa5A-2bf6A:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d2z | CHLORIDEINTRACELLULARCHANNEL PROTEIN 4 (Homo sapiens) |
PF13410(GST_C_2) | 5 | GLU A 93ALA A 187GLU A 92ARG A 40ASN A 190 | None | 1.50A | 4wa5A-2d2zA:undetectable | 4wa5A-2d2zA:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2f28 | SIALIDASE 2 (Homo sapiens) |
PF13088(BNR_2) | 5 | ARG A 21GLU A 218ARG A 237ARG A 304TYR A 334 | None | 0.42A | 4wa5A-2f28A:5.7 | 4wa5A-2f28A:21.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fpg | SUCCINYL-COA LIGASE[GDP-FORMING]ALPHA-CHAIN,MITOCHONDRIALSUCCINYL-COA LIGASE[GDP-FORMING]BETA-CHAIN,MITOCHONDRIAL (Sus scrofa) |
PF00549(Ligase_CoA)PF02629(CoA_binding)PF08442(ATP-grasp_2) | 5 | GLU A 224ALA A 247GLU A 223ARG A 161ARG B 123 | None | 1.44A | 4wa5A-2fpgA:undetectable | 4wa5A-2fpgA:22.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | ARG A 118ASP A 151GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | None | 0.51A | 4wa5A-2htvA:67.7 | 4wa5A-2htvA:61.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 6 | GLU A 119GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | None | 0.86A | 4wa5A-2htvA:67.7 | 4wa5A-2htvA:61.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qxl | HEAT SHOCK PROTEINHOMOLOG SSE1 (Saccharomycescerevisiae) |
PF00012(HSP70) | 5 | GLU A 646GLU A 587GLU A 588ARG A 639TYR A 642 | None | 1.46A | 4wa5A-2qxlA:undetectable | 4wa5A-2qxlA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vbi | PYRUVATEDECARBOXYLASE (Acetobacterpasteurianus) |
PF00205(TPP_enzyme_M)PF02775(TPP_enzyme_C)PF02776(TPP_enzyme_N) | 5 | GLU A 90ALA A 418GLU A 58ASN A 421ARG A 221 | None | 1.12A | 4wa5A-2vbiA:undetectable | 4wa5A-2vbiA:21.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w20 | SIALIDASE A (Streptococcuspneumoniae) |
PF13088(BNR_2) | 6 | ARG A 347ASP A 372GLU A 647ARG A 663ARG A 721TYR A 752 | None | 0.79A | 4wa5A-2w20A:13.5 | 4wa5A-2w20A:22.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xzi | EXTRACELLULARSIALIDASE/NEURAMINIDASE, PUTATIVE (Aspergillusfumigatus) |
PF13088(BNR_2) | 6 | ARG A 59ASP A 84GLU A 249ARG A 265ARG A 322TYR A 358 | KDM A 500 (-2.7A)KDM A 500 (-2.8A)KDM A 500 (-3.6A)KDM A 500 (-2.7A)KDM A 500 ( 3.0A)KDM A 500 (-4.5A) | 0.77A | 4wa5A-2xziA:9.8 | 4wa5A-2xziA:23.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yw2 | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Aquifexaeolicus) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ARG A 378GLU A 100GLU A 71ARG A 287ASN A 285 | PO4 A 645 (-3.6A)NonePO4 A 645 (-2.9A)PO4 A 645 (-3.3A)None | 1.18A | 4wa5A-2yw2A:undetectable | 4wa5A-2yw2A:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yw2 | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Aquifexaeolicus) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ARG A 378GLU A 100GLU A 71ARG A 287TYR A 269 | PO4 A 645 (-3.6A)NonePO4 A 645 (-2.9A)PO4 A 645 (-3.3A)None | 1.16A | 4wa5A-2yw2A:undetectable | 4wa5A-2yw2A:22.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119ASP A 151GLU A 227GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 ( 4.8A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.54A | 4wa5A-3ckzA:67.5 | 4wa5A-3ckzA:57.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 ( 4.8A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.45A | 4wa5A-3ckzA:67.5 | 4wa5A-3ckzA:57.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h1l | CYTOCHROME BMITOCHONDRIALUBIQUINOL-CYTOCHROMEC REDUCTASE 14 KDAPROTEIN (Gallus gallus) |
PF00032(Cytochrom_B_C)PF00033(Cytochrome_B)PF02271(UCR_14kD) | 5 | GLU F 39ASP C 215ARG C 314ASN C 207TYR C 110 | NoneNoneNoneHEM C 502 (-4.5A)None | 1.36A | 4wa5A-3h1lF:undetectable | 4wa5A-3h1lF:13.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3j0h | PHIKZ029 (Pseudomonasvirus phiKZ) |
no annotation | 5 | GLU A 218ASP A 215GLU A 221ASN A 259TYR A 257 | None | 1.35A | 4wa5A-3j0hA:undetectable | 4wa5A-3j0hA:20.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3juu | PORPHYRANASE B (Zobelliagalactanivorans) |
PF00722(Glyco_hydro_16) | 5 | ARG A 70GLU A 256GLU A 161ASN A 183TYR A 258 | GOL A 294 (-3.3A)GOL A 294 (-2.7A)GOL A 294 (-3.1A)NoneNone | 1.38A | 4wa5A-3juuA:undetectable | 4wa5A-3juuA:18.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lp8 | PHOSPHORIBOSYLAMINE-GLYCINE LIGASE (Ehrlichiachaffeensis) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ARG A 380GLU A 100GLU A 71ARG A 287ASN A 285 | UNX A 425 ( 4.0A)NoneNoneNoneNone | 1.32A | 4wa5A-3lp8A:undetectable | 4wa5A-3lp8A:23.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sil | SIALIDASE (Salmonellaenterica) |
PF13859(BNR_3) | 6 | ARG A 37ASP A 62GLU A 231ARG A 246ARG A 309TYR A 342 | PO4 A 499 (-2.7A)GOL A 403 ( 3.4A)GOL A 402 (-3.3A)PO4 A 499 (-2.7A)PO4 A 499 (-3.0A)PO4 A 499 (-4.6A) | 0.87A | 4wa5A-3silA:12.6 | 4wa5A-3silA:23.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119ASP A 151GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | LNV A 901 (-3.0A)LNV A 901 (-3.6A)LNV A 901 (-3.4A)LNV A 901 (-3.4A)LNV A 901 (-3.5A)LNV A 901 (-2.9A)LNV A 901 ( 3.8A)LNV A 901 (-2.8A)LNV A 901 (-4.0A)LNV A 901 ( 4.7A)LNV A 901 (-2.9A)LNV A 901 (-4.8A) | 0.52A | 4wa5A-3ti8A:72.8 | 4wa5A-3ti8A:69.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ASP A 151ARG A 371TYR A 406ARG A 292TYR A 347 | LNV A 901 (-3.4A)LNV A 901 (-2.9A)LNV A 901 (-4.8A)LNV A 901 (-2.8A)LNV A 901 ( 4.7A) | 0.92A | 4wa5A-3ti8A:72.8 | 4wa5A-3ti8A:69.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tia | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | LNV A 801 (-2.8A)LNV A 801 (-3.5A)LNV A 801 (-3.4A)LNV A 801 (-3.5A)LNV A 801 (-3.4A)LNV A 801 (-2.9A)LNV A 801 (-3.8A)LNV A 801 (-3.0A)LNV A 801 (-4.0A)LNV A 801 (-2.9A)LNV A 801 (-4.4A) | 0.52A | 4wa5A-3tiaA:63.0 | 4wa5A-3tiaA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119ASP A 151GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.69A | 4wa5A-4b7jA:67.8 | 4wa5A-4b7jA:49.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bbw | SIALIDASE(NEURAMINIDASE) (Bacteroidesthetaiotaomicron) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 6 | ARG A 204ASP A 229GLU A 399ARG A 415ARG A 479TYR A 510 | None | 1.19A | 4wa5A-4bbwA:22.1 | 4wa5A-4bbwA:21.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cpn | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 10 | ARG A 115GLU A 116ASP A 148GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.56A | 4wa5A-4cpnA:52.8 | 4wa5A-4cpnA:31.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cpn | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 10 | ARG A 115GLU A 116GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.43A | 4wa5A-4cpnA:52.8 | 4wa5A-4cpnA:31.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fj6 | GLYCOSIDE HYDROLASEFAMILY 33, CANDIDATESIALIDASE (Parabacteroidesdistasonis) |
PF13859(BNR_3)PF14873(BNR_assoc_N) | 5 | ARG A 200GLU A 395ARG A 411ARG A 475TYR A 506 | PO4 A 607 ( 2.6A)PO4 A 607 ( 4.8A)PO4 A 607 (-2.7A)PO4 A 607 (-2.8A)PO4 A 607 (-4.6A) | 0.42A | 4wa5A-4fj6A:21.9 | 4wa5A-4fj6A:21.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fzh | HEMAGGLUTININ-NEURAMINIDASE (Avianavulavirus 1) |
PF00423(HN) | 5 | ARG A 174GLU A 401ARG A 416ARG A 498TYR A 526 | None | 0.63A | 4wa5A-4fzhA:4.9 | 4wa5A-4fzhA:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fzh | HEMAGGLUTININ-NEURAMINIDASE (Avianavulavirus 1) |
PF00423(HN) | 5 | ASP A 198GLU A 401ARG A 416ARG A 498TYR A 526 | None | 1.06A | 4wa5A-4fzhA:4.9 | 4wa5A-4fzhA:21.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119ASP A 151GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371 | SLB A 512 (-2.7A)SLB A 512 (-3.5A)SLB A 512 (-3.5A)NoneSLB A 512 (-3.3A)SLB A 512 (-2.8A)SLB A 512 (-2.7A)SLB A 512 (-3.1A)SLB A 512 ( 4.2A)SLB A 512 (-2.9A) | 0.58A | 4wa5A-4h53A:63.3 | 4wa5A-4h53A:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119ASP A 151GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.66A | 4wa5A-4hzzA:62.1 | 4wa5A-4hzzA:47.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 8 | GLU A 119ASP A 151GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.95A | 4wa5A-4hzzA:62.1 | 4wa5A-4hzzA:47.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jf7 | HEMAGGLUTININ-NEURAMINIDASE (Mammalianrubulavirus 5) |
no annotation | 6 | ARG D 163GLU D 390ARG D 405ASN D 407ARG D 495TYR D 523 | SO4 D 608 ( 4.1A)NoneSO4 D 608 (-2.6A)NoneSO4 D 608 (-3.3A)None | 0.71A | 4wa5A-4jf7D:22.1 | 4wa5A-4jf7D:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mel | UBIQUITINCARBOXYL-TERMINALHYDROLASE 11 (Homo sapiens) |
PF06337(DUSP)PF14836(Ubiquitin_3) | 5 | GLU A 71GLU A 50GLU A 43ARG A 49TYR A 67 | None | 1.41A | 4wa5A-4melA:undetectable | 4wa5A-4melA:20.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118ASP A 151GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.57A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118ASP A 151GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)None27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.59A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ASP A 151GLU A 119TYR A 347ARG A 371TYR A 406 | 27S A 501 (-3.2A)27S A 501 (-3.4A)None27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.32A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 8 | GLU A 119ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.94A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.15A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n5f | PUTATIVE ACYL-COADEHYDROGENASE (Burkholderiacenocepacia) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 5 | ARG A 17ASP A 259ALA A 289ARG A 296ASN A 293 | None | 1.27A | 4wa5A-4n5fA:undetectable | 4wa5A-4n5fA:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n5f | PUTATIVE ACYL-COADEHYDROGENASE (Burkholderiacenocepacia) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 5 | ARG A 17GLU A 75ALA A 289ARG A 296ASN A 293 | None | 1.42A | 4wa5A-4n5fA:undetectable | 4wa5A-4n5fA:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ovt | TRAP DICARBOXYLATETRANSPORTER, DCTPSUBUNIT (Ochrobactrumanthropi) |
PF03480(DctP) | 5 | GLU A 208ARG A 149ASN A 209TYR A 146TYR A 105 | NoneLFC A 403 (-2.7A)LFC A 403 (-2.9A)LFC A 403 (-4.2A)None | 1.45A | 4wa5A-4ovtA:undetectable | 4wa5A-4ovtA:19.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q6k | BNR/ASP-BOX REPEATPROTEIN (Bacteroidescaccae) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 6 | ARG A 220ASP A 245GLU A 415ARG A 431ARG A 495TYR A 526 | EDO A 604 (-4.0A)EDO A 604 ( 4.3A)NoneNoneNoneNone | 0.74A | 4wa5A-4q6kA:5.8 | 4wa5A-4q6kA:22.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qn3 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 36GLU A 37ASP A 69GLU A 146ALA A 165GLU A 195GLU A 196ARG A 211ASN A 213ARG A 290TYR A 324 | None | 0.52A | 4wa5A-4qn3A:62.4 | 4wa5A-4qn3A:44.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4sli | INTRAMOLECULARTRANS-SIALIDASE (Macrobdelladecora) |
PF02973(Sialidase)PF13088(BNR_2) | 5 | ALA A 592GLU A 595ARG A 611ARG A 673TYR A 713 | NoneCNP A 760 ( 4.5A)CNP A 760 (-3.0A)CNP A 760 (-3.0A)CNP A 760 (-4.0A) | 1.07A | 4wa5A-4sliA:13.1 | 4wa5A-4sliA:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4sli | INTRAMOLECULARTRANS-SIALIDASE (Macrobdelladecora) |
PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 293ASP A 318GLU A 595ARG A 611ARG A 673TYR A 713 | CNP A 760 (-3.0A)CNP A 760 (-2.6A)CNP A 760 ( 4.5A)CNP A 760 (-3.0A)CNP A 760 (-3.0A)CNP A 760 (-4.0A) | 0.72A | 4wa5A-4sliA:13.1 | 4wa5A-4sliA:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4txk | PROTEIN-METHIONINESULFOXIDE OXIDASEMICAL1 (Mus musculus) |
PF00307(CH)PF01494(FAD_binding_3) | 5 | ARG A 230GLU A 373ALA A 473GLU A 437ARG A 371 | None | 1.18A | 4wa5A-4txkA:undetectable | 4wa5A-4txkA:20.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x6k | ANHYDROSIALIDASE ([Ruminococcus]gnavus) |
PF13088(BNR_2) | 6 | ARG A 257ALA A 556GLU A 559ARG A 575ARG A 637TYR A 677 | 3XR A 802 (-3.0A)None3XR A 802 ( 4.7A)3XR A 802 (-2.6A)3XR A 802 (-3.0A)3XR A 802 (-4.2A) | 1.09A | 4wa5A-4x6kA:18.8 | 4wa5A-4x6kA:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x6k | ANHYDROSIALIDASE ([Ruminococcus]gnavus) |
PF13088(BNR_2) | 6 | ARG A 257ASP A 282GLU A 559ARG A 575ARG A 637TYR A 677 | 3XR A 802 (-3.0A)3XR A 802 (-2.5A)3XR A 802 ( 4.7A)3XR A 802 (-2.6A)3XR A 802 (-3.0A)3XR A 802 (-4.2A) | 0.68A | 4wa5A-4x6kA:18.8 | 4wa5A-4x6kA:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xhb | SIALIDASE B (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 5 | ALA A 538GLU A 541ARG A 557ARG A 619TYR A 653 | NoneNoneNHE A 702 (-2.8A)NHE A 702 (-2.9A)NHE A 702 (-4.8A) | 1.23A | 4wa5A-4xhbA:13.2 | 4wa5A-4xhbA:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xhb | SIALIDASE B (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 245ASP A 270GLU A 541ARG A 557ARG A 619TYR A 653 | NHE A 702 (-2.7A)NHE A 702 (-3.2A)NoneNHE A 702 (-2.8A)NHE A 702 (-2.9A)NHE A 702 (-4.8A) | 0.79A | 4wa5A-4xhbA:13.2 | 4wa5A-4xhbA:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 5 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.44A | 4wa5A-4yw5A:10.3 | 4wa5A-4yw5A:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b2d | HN PROTEIN (Mumpsrubulavirus) |
PF00423(HN) | 5 | ARG A 180GLU A 407ARG A 422ARG A 512TYR A 540 | SLT A 606 (-2.6A)SLT A 606 (-3.8A)SLT A 606 (-3.0A)SLT A 606 (-2.8A)SLT A 606 (-4.7A) | 0.50A | 4wa5A-5b2dA:22.1 | 4wa5A-5b2dA:21.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5czz | CRISPR-ASSOCIATEDENDONUCLEASE CAS9 (Staphylococcusaureus) |
PF13395(HNH_4)PF16592(Cas9_REC) | 5 | ARG A 92GLU A 179ALA A 144ASN A 141TYR A 176 | None | 1.36A | 4wa5A-5czzA:undetectable | 4wa5A-5czzA:14.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mzo | UDP-GLUCOSE-GLYCOPROTEINGLUCOSYLTRANSFERASE-LIKE PROTEIN (Chaetomiumthermophilum) |
PF06427(UDP-g_GGTase) | 5 | ASP A 165GLU A1064GLU A1123ARG A 215TYR A 122 | None | 1.35A | 4wa5A-5mzoA:undetectable | 4wa5A-5mzoA:14.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uou | 2-OXO-4-HYDROXY-4-CARBOXY-5-UREIDOIMIDAZOLINE (OHCU)DECARBOXYLASE (Klebsiellapneumoniae) |
PF09349(OHCU_decarbox) | 5 | ALA A 150GLU A 147GLU A 144ARG A 136TYR A 109 | None | 1.46A | 4wa5A-5uouA:undetectable | 4wa5A-5uouA:17.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y7i | CHLORIDEINTRACELLULARCHANNEL PROTEIN 2 (Oreochromismossambicus) |
no annotation | 5 | GLU A 88ALA A 180GLU A 87ARG A 35ASN A 183 | None | 1.19A | 4wa5A-5y7iA:undetectable | 4wa5A-5y7iA:12.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6br6 | NEURAMINIDASE (Influenza Avirus) |
no annotation | 11 | ARG A 118GLU A 119ASP A 151GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.44A | 4wa5A-6br6A:63.4 | 4wa5A-6br6A:12.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6eks | SIALIDASE (Vibrio cholerae) |
no annotation | 5 | ARG A 250ASP A 276ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.65A | 4wa5A-6eksA:3.7 | 4wa5A-6eksA:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6eks | SIALIDASE (Vibrio cholerae) |
no annotation | 5 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.34A | 4wa5A-6eksA:3.7 | 4wa5A-6eksA:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fel | 14-3-3 PROTEIN GAMMA (Homo sapiens) |
no annotation | 5 | ARG A 61GLU A 185ARG A 132ASN A 178ARG A 57 | None | 1.14A | 4wa5A-6felA:undetectable | 4wa5A-6felA:12.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG N 152ARG N 156TRP N 178ILE N 222ARG N 224 | None | 0.63A | 4wa5A-1nmbN:61.3 | 4wa5A-1nmbN:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v0z | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 158ARG A 162TRP A 185ILE A 229ARG A 231 | None | 0.57A | 4wa5A-1v0zA:62.9 | 4wa5A-1v0zA:48.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 5 | ARG A 150ARG A 154TRP A 177ILE A 221ARG A 223 | IBA A 1 (-3.9A)IBA A 1 (-4.1A)NoneIBA A 1 ( 4.3A)IBA A 1 ( 4.5A) | 0.72A | 4wa5A-1vcjA:52.5 | 4wa5A-1vcjA:35.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 153ARG A 157TRP A 180ILE A 224ARG A 226 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A)None | 0.64A | 4wa5A-1xogA:62.3 | 4wa5A-1xogA:44.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224 | None | 0.59A | 4wa5A-2htvA:67.7 | 4wa5A-2htvA:61.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nwb | CONSERVED DOMAINPROTEIN (Shewanellaoneidensis) |
PF08933(DUF1864) | 4 | ARG A 368ARG A 369ILE A 377ARG A 374 | NoneHEM A 401 (-2.2A)NoneNone | 1.20A | 4wa5A-2nwbA:undetectable | 4wa5A-2nwbA:23.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.75A | 4wa5A-3ckzA:67.5 | 4wa5A-3ckzA:57.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 152TRP A 178ILE A 222ARG A 224 | ZMR A 469 (-3.9A)NoneNoneZMR A 469 (-4.4A) | 0.30A | 4wa5A-3ckzA:67.5 | 4wa5A-3ckzA:57.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224 | LNV A 901 (-4.0A)LNV A 901 (-4.0A)NoneNoneLNV A 901 (-4.1A) | 0.55A | 4wa5A-3ti8A:72.8 | 4wa5A-3ti8A:69.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tia | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224 | LNV A 801 (-3.9A)LNV A 801 (-4.0A)NoneNoneLNV A 801 (-4.2A) | 0.52A | 4wa5A-3tiaA:63.0 | 4wa5A-3tiaA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 152ARG A 156TRP A 179ARG A 225 | G39 A1470 (-3.9A)NoneNoneG39 A1470 (-4.4A) | 0.65A | 4wa5A-4b7jA:67.8 | 4wa5A-4b7jA:49.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cpn | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 5 | ARG A 149ARG A 153TRP A 176ILE A 220ARG A 222 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNoneZMR A 700 (-3.8A) | 0.54A | 4wa5A-4cpnA:52.8 | 4wa5A-4cpnA:31.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224 | SLB A 512 (-3.8A)NoneNoneNoneSLB A 512 (-4.2A) | 0.53A | 4wa5A-4h53A:63.3 | 4wa5A-4h53A:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A)G39 A 509 (-4.7A) | 0.54A | 4wa5A-4hzzA:62.1 | 4wa5A-4hzzA:47.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A) | 0.69A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qn3 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 70ARG A 74TRP A 97ILE A 141ARG A 143 | None | 0.64A | 4wa5A-4qn3A:62.4 | 4wa5A-4qn3A:44.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j9q | ENHANCER OFPOLYCOMB-LIKEPROTEIN 1 (Saccharomycescerevisiae) |
no annotation | 4 | ARG G 282TRP G 279ILE G 214ARG G 280 | None | 1.46A | 4wa5A-5j9qG:undetectable | 4wa5A-5j9qG:21.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6br6 | NEURAMINIDASE (Influenza Avirus) |
no annotation | 5 | ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A)E3M A 511 (-3.8A) | 0.52A | 4wa5A-6br6A:63.4 | 4wa5A-6br6A:12.69 |